And What Elon Musk and Kevin Dolan Are Missing About Population & Demographic Collapse
While I do not personally know either of these individuals, I am familiar with their concerns regarding declining birth rates and the potential for demographic collapse. This essay is not intended as a personal critique, but rather as an examination of a critical gap in the current discussion: key variables are being overlooked, and conclusions are being drawn using outdated modeling assumptions.
The goal here is to explain why these concerns, while understandable, may be incomplete. They do not fully account for several rapidly emerging factors that have the potential to fundamentally alter demographic trajectories. For context, I am referring to discussions such as this:
Kevin Dolan on birth rates and civilization
And public posts such as these:
Elon Musk post on population decline
Elon Musk post on demographic collapse
So what is it that they are missing?
The demographic projections underlying these concerns fail to account for a critical variable: near-term biomedical and biotechnological breakthroughs. Most current models implicitly assume that aging populations will follow the historical pattern—progressive decline into frailty, chronic illness, and dependency. In this framework, older individuals are expected to become increasingly unable to care for themselves or contribute productively, placing a growing burden on younger generations.
That outcome is certainly plausible—if we continue allocating resources poorly, or if external shocks such as economic collapse intervene. But it is not the only trajectory.
If resources are directed toward solving the right problems, an entirely different future emerges—one in which extended lifespan is matched by extended healthspan. In that scenario, older individuals remain physically capable, cognitively intact, and economically productive for far longer than current models assume. Rather than becoming a net societal burden, they may require minimal support—potentially less than what is required today.
Aging only becomes a demographic burden if aging continues to mean decline.
This matters because the entire concern about demographic collapse is built around the assumption that a growing elderly population automatically increases dependency. But that assumption only holds if aging continues to produce dependency. If aging is mitigated or reversed, then the concept of the “dependency ratio” itself becomes outdated.
The problem is not simply that there may be too few young people. The problem is that we are assuming older people will remain biologically limited in the same way they always have been.
So the real question is not whether aging populations are a problem, but whether we are choosing to solve aging itself.
State Changes and Why the Future Is Not Like the Past
Humans naturally rely on the past to predict the future. We look at how the world has changed over the last 50 years, project those trends forward another 50, and assume the result will be directionally reliable. That approach may have worked in periods of slow, incremental change. It breaks down entirely in periods of rapid technological and societal transformation—such as the one we are now entering.
To understand why, consider a simple physical analogy: a phase transition. An ice cube taken from a freezer at 20°F can sit at room temperature and gradually warm to 31°F with very little visible change. It remains solid—recognizably the same object. But the transition from 32°F to 33°F is fundamentally different. In that narrow window, the system undergoes a rapid transformation into an entirely new state. Or, as Hemingway described change: “gradually, then suddenly.”
This concept extends far beyond physics. Similar “state changes” occur in technology, economics, politics, and culture—periods where long stretches of apparent stability are followed by rapid, nonlinear shifts. This is also captured by the aphorism, “there are decades where nothing happens; and there are weeks where decades happen.”
Gradually… then suddenly. Most models fail right here.
Today, biomedical science and biotechnology appear to be approaching such a threshold. We are not yet at the point of transformation—but we are close. And when that threshold is crossed, the resulting changes are likely to be rapid, profound, and disruptive to existing assumptions.
This is why demographic models that extrapolate from the past may be misleading. They may accurately describe the world as it has been, but fail to account for the world that may be emerging.
What does that mean in practical terms?
If resources are deployed effectively, both human healthspan and lifespan will be extended in ways that current models fail to anticipate. The focus shifts from managing decline to maintaining function. Under that paradigm, conditions such as neurodegeneration, cardiovascular disease, and cancer become increasingly treatable—and ultimately preventable—rather than inevitable features of aging. Even biological aging itself becomes a legitimate target for intervention.
The result is not simply longer life, but longer functional life. Individuals remain physically capable, cognitively intact, and able to participate meaningfully in society for far more years than current assumptions allow. The concept of the “elderly” as a dependent class begins to break down.
Such a shift would not be incremental. It would force a broad restructuring of cultural, economic, and political systems. Institutions built around predictable decline—retirement, entitlement programs, workforce dynamics—would need to be rethought from the ground up. That transformation is substantial, but it is secondary to the underlying reality: extending healthy human function fundamentally changes the structure of society.
There is also a timing issue that is often missed. The timeline of concern and the timeline of possible solutions overlap. The same decades in which demographic pressure is expected to increase are also the decades in which breakthroughs in healthspan extension are most likely to emerge. Ignoring one while projecting the other creates a distorted picture of the future.
If predictions about the future of civilization were expressed mathematically, they would resemble a system of continuously changing variables over time—far too complex to reduce to a handful of inputs. Birth rates matter, but so do healthspan, lifespan, productivity, automation, disease burden, medical innovation, economics, war, culture, migration, and countless other factors.
You cannot isolate a small subset of variables—such as birth rates—and assume the rest will remain static. Doing so does not simplify the model; it distorts it. The result is not just incomplete, but potentially misleading.
The greater risk is not that individual variables are slightly misestimated, but that entire variables are omitted altogether. This is the domain of what Nassim Nicholas Taleb describes as “black swan” events—factors that are unknown, unmodeled, and often only recognized in hindsight.
The challenge, of course, is that for a system as complex as population dynamics, we cannot fully enumerate all relevant variables. Our projections are constrained not only by available data, but by the limits of our imagination and the biases embedded in our current models—particularly during periods of rapid technological and economic change.
Those changes may be profoundly positive—breakthroughs in health, longevity, and biotechnology—or profoundly negative—economic disruption, geopolitical conflict, environmental stressors. Most likely, they will be some combination of both.
All of these forces interact, and all of them influence demographic outcomes.
History makes this clear. World War II dramatically impacted mortality, and the post-war period dramatically impacted birth rates. Major events can change demographic trajectories quickly and unpredictably.
Given the current state of the world, it would be unrealistic to assume that the next several decades will follow a smooth or predictable path.
Too Many People, or Too Few? The “Goldilocks” Problem
Some “neomalthusians” argue that the world already has too many people for its available resources. Others—such as Elon Musk and Kevin Dolan—warn of the opposite: a future with too few people to sustain economic growth and societal stability.
Both perspectives are rooted in a similar assumption—that there exists some “optimal” human population size. But in practice, no one knows what that number is, or even whether such a number can be meaningfully defined in a decentralized, non–centrally planned world.
History suggests caution when attempting to engineer population outcomes. Large-scale interventions—such as China’s one-child policy—have produced significant and often unintended distortions. More broadly, economic theory, from thinkers like Ludwig von Mises, has consistently shown that central planning tends to generate inefficiencies and long-term instability.
At the same time, demographic forces are not unidirectional. Some factors push population upward; others pull it downward. As societies become more affluent, birth rates tend to decline—a trend already visible across developed nations. While developing regions still exhibit higher birth rates, these too are generally trending downward over time.
For the purposes of this discussion, the specific causes of these trends are less important than recognizing their existence. The key point is that multiple, opposing forces are already in motion.
What is often overlooked is how longevity fundamentally alters this equation.
One of the most common objections to extending human lifespan is the risk of overpopulation. Notably, this is not an argument about feasibility, but about desirability. It assumes that longer life, combined with existing reproductive patterns, would lead to unsustainable population growth.
But that assumption depends on holding other variables constant—particularly birth rates.
In reality, human behavior is not static. Some individuals will choose to have children; others will not. Some may choose to have more children in a longer-lived world; others may delay or opt out entirely. Similarly, while many people will likely adopt life- and health-extending therapies, some will decline them for philosophical, cultural, or religious reasons—just as a minority today still avoids interventions like antibiotics.
The result is not a single, predictable trajectory, but a dynamic system with offsetting trends.
It is entirely plausible that declining birth rates and increasing longevity could partially—or even substantially—balance one another. A slower turnover of human life, characterized by fewer births and fewer deaths, may stabilize population dynamics in ways that current models fail to anticipate.
This does not imply certainty; it suggests opportunity. It also highlight the danger of drawing definitive conclusions from incomplete assumptions.
There is also the question of labor. Historically, population size mattered because human labor was the primary driver of economic output. That relationship is already changing. As automation and artificial intelligence continue to expand, the number of people required to sustain and grow an economy may decrease, while the value of experienced, high-capability individuals may increase.
Labor scarcity does not automatically equal civilizational collapse. If productivity per person rises, and if technology reduces the need for repetitive human labor, then a smaller population does not necessarily mean a weaker civilization. It may mean a different civilization.
This analysis still excludes additional variables—such as technological expansion beyond Earth—which could further reshape long-term population constraints.
Before we can fully evaluate these possibilities, however, we must first rethink a more fundamental question:
What does it actually mean to extend human lifespan?
Wisdom Versus Youth—or Wisdom and Youth
Consider a simple thought experiment. Imagine that by 2040, therapies exist that can maintain an individual’s health at the biological equivalent of a fit 40-year-old—indefinitely. Not the peak physicality of a 20-year-old, but also not the decline typically associated with advanced age.
Now imagine someone born in 1930—over a century of lived experience—retaining that accumulated knowledge and perspective, while also possessing the cognitive function and physical capability of a healthy 40-year-old.
Who contributes more to society: a typical 40-year-old, or a 40-year-old with 110 years of experience?
The answer is not ambiguous. Experience compounds. Knowledge compounds. Judgment improves with time—assuming it is preserved.
This reframes a long-standing paradox. We often say that those who fail to learn from history are doomed to repeat it. We also observe that, in practice, societies frequently fail to learn from history and do repeat the same mistakes. But this dynamic is driven, in part, by generational turnover. Knowledge is lost as individuals age and are replaced, forcing each generation to relearn lessons that were already paid for—sometimes at enormous cost.
What if that cycle were broken?
If individuals could retain both the wisdom of age and the functional capacity of midlife, the need to continuously relearn historical lessons could diminish. Progress would no longer be constrained by the reset mechanism of generational replacement.
This has implications far beyond individual productivity. If capable people remain productive for longer, innovation itself may accelerate. Instead of expertise resetting every few decades, that expertise could have a continuous, compounding presence. Scientific, technological, and cultural progress would no longer be interrupted as frequently by the biological limits of the people carrying that knowledge forward.
There may also be implications for political and institutional stability. Many large-scale societal failures are driven by short-term thinking, loss of institutional memory, and repeated cycles of avoidable mistakes. A longer-lived, cognitively intact population may be better equipped to think across longer time horizons and preserve hard-won lessons.
The result is not merely longer-lived individuals, but a fundamentally more experienced, wise—and potentially more stable—civilization.
A longer-lived, healthier civilization is not simply older. It is more experienced and wiser.
Future Demographic Collapse Can Be Avoided—If Resources Are Deployed Wisely
This brings us to a critical constraint: how resources are actually allocated.
Based on my experience in biopharma R&D and clinical healthcare, a substantial portion of funding directed toward biomedical research fails to produce meaningful, transformative outcomes. This is not due to a lack of intelligence or effort, but rather the intersection of incentives and strategy.
At a high level, research efforts tend to fall into three categories:
- The business approach — prioritizes financial return, with health outcomes often secondary
- The academic approach — prioritizes knowledge generation, proof, and publication; not real world clinical results
- The engineering approach — prioritizes building functional, real-world solutions
In practice, the majority of funding flows into the first two categories, while comparatively little is directed toward the third.
Each approach has value—but each also has limitations.
The business approach tends to favor incremental improvements that are commercially viable, but rarely transformative. The academic approach, while essential for advancing understanding, often operates under the implicit assumption that time is unlimited—requiring exhaustive validation before real-world application is considered.
But in reality, time is not unlimited. It is arguably the most scarce resource we have.
From a practical standpoint, the engineering approach—focused on developing interventions that are safe, effective, and deployable—becomes essential if the goal is to meaningfully extend healthspan and lifespan within relevant time horizons.
Critics often argue that such an approach is premature—that mechanisms must be fully understood before intervention. Yet history suggests otherwise. Widely used therapies such as aspirin were deployed safely and effectively for decades before their mechanisms of action were fully understood. “Don’t let the perfect be the enemy of the good.”
The implication is not that rigor should be abandoned, but that an overemphasis on perfect understanding can delay meaningful progress—particularly when the cost of delay is measured in human health and lives lost.
To make this more concrete, there are therapeutic approaches to extending lifespan and healthspan that have been discussed in the scientific literature for over two decades—yet remain largely undeveloped due to insufficient and misdirected funding.
The level of investment required to meaningfully advance some of these approaches is not measured in billions, but in tens of millions of dollars—if applied strategically. In the context of global biomedical spending, this is negligible. It is a fraction of what is routinely allocated by institutions such as the NIH and NIA, as well as private companies and foundations—often toward less transformative avenues.
It is also insignificant compared to the growing financial burden of aging populations on healthcare systems worldwide—costs that are already straining, and in some cases threatening, the long-term stability of national economies.
An aging population is currently viewed as a cost center. But if aging is addressed, that same population becomes a retained asset—one that continues producing economic value rather than consuming it.
The issue, therefore, is not a lack of resources. It is a question of prioritization.
Below are representative publications supporting just one class of therapeutic approaches that has remained underfunded despite its potential relevance to both healthspan extension and demographic stability:
- https://www.nature.com/articles/nature09603
- https://www.sciencedirect.com/science/article/abs/pii/S0092867424005920
- https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.12012
- https://www.mdpi.com/2079-7737/11/12/1768
- https://exponentialtherapeutics.com/references-and-supporting-information/
The broader scientific framework is already in place. The core mechanisms underlying aging—often described as the “hallmarks of aging”—are increasingly well characterized and, in many cases, technically addressable.
The remaining question is straightforward:
Will resources be directed toward developing real-world interventions, or will they continue to be diluted across less impactful applications?
Because the answer to that question will determine whether projected demographic challenges materialize—or are largely avoided.
Conclusion
Birth rates are falling. People are living longer. There are more elderly people in our societies.
All true.
But does that automatically mean demographic collapse?
No.
That conclusion only holds if we assume aging remains an unsolved problem. If we instead treat aging like what it is—an engineering problem—then the entire equation changes.
The most civilization-promoting and humane thing we can do is keep people who are already here, healthy, capable, and alive longer—not necessarily bring more people into the world who then need 20+ years of development before they can contribute meaningfully.
A 110-year-old unconstrained by the limits of biology will almost certainly be able to contribute more than a typical 40-year-old—and definitely more, and more quickly, than an infant. And that advantage compounds across an entire population.
Not to belittle the incredible value of human life with a crude analogy—but it is still a useful one: if you extend the productive life of an existing investment, you increase the overall productivity of the system. Anyone who has raised a child knows that getting a human from infancy to a capable, educated adult is an incredibly capital-intensive process.
Longevity science does not replace that. It simply makes that system more efficient.
This is not an argument against having children. It is an argument against assuming that fewer children automatically leads to collapse. That conclusion only makes sense if everything else stays the same—and it will almost certainly not.
What matters is not just how many people exist, but how long they remain healthy, capable, and able to contribute.
What if, dramatically improving human healthspan and lifespan turns out to be the real breakthrough that drives global prosperity for the rest of this century?
Demographic change is coming either way.
The only real question is whether we choose to make it a problem—or a solution.
PS — The first time I read that Elon wanted to “die on Mars,” I remember thinking:
Why does he want to die so young?